[Characteristics of peptide vagotropic effects during subtotal blockade of heart M-cholinoreceptors].
Osadchiĭ
O E
OE
Pokrovskiĭ
V M
VM
D000818:Animals; D001561:Benzilates / Q000494:pharmacology; D002415:Cats; D002595:Cevanes / Q000494:pharmacology; D002794:Choline / Q000031:analogs & derivatives / Q000494:pharmacology; D004558:Electric Stimulation; D004744:Enkephalin, Methionine / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects* / Q000502:physiology; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D018727:Muscarinic Antagonists / Q000494:pharmacology*; D009206:Myocardium / Q000378:metabolism; D043585:Receptor, Muscarinic M2; D011976:Receptors, Muscarinic / Q000187:drug effects* / Q000378:metabolism; D013004:Somatostatin / Q000494:pharmacology*; D014630:Vagus Nerve / Q000187:drug effects* / Q000502:physiology
D001561:Benzilates; D002595:Cevanes; D018727:Muscarinic Antagonists; D043585:Receptor, Muscarinic M2; D011976:Receptors, Muscarinic; C053908:metacine; D013004:Somatostatin; D004744:Enkephalin, Methionine; C047331:peiminine; D002794:Choline
Osobennosti vagotropnogo deĭstviia peptidov v usloviiakh subtotal'noĭ blokady M-kholinoretseptorov sesrdtsa.